Dfpg Investments, LLC Eli Lilly & CO Transaction History

Dfpg Investments, LLC

$1.29 Billion
Q4 2023

A detailed history of Dfpg Investments, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Dfpg Investments, LLC holds 6,088 shares of LLY stock, worth $5.52 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

6,088

Previous 6,033 0.91%

Holding current value

$5.52 Million

Previous $3.24 Million 9.51%

% of portfolio

0.27%

Previous 0.3%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 09, 2024	BUY	$525.19 - $619.13 $28,885 - $34,052	55 Added 0.91%	6,088 $3.55 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $87,809 - $121,058	202 Added 3.46%	6,033 $3.24 Million
Q2 2023 Jul 24, 2023	BUY	$350.74 - $468.98 $139,945 - $187,123	399 Added 7.35%	5,831 $2.73 Million
Q1 2023 Apr 10, 2023	BUY	$310.63 - $364.82 $64,611 - $75,882	208 Added 3.98%	5,432 $1.87 Million
Q4 2022 Feb 02, 2023	BUY	$321.55 - $374.67 $597,761 - $696,511	1,859 Added 55.25%	5,224 $1.91 Million

Q2 2022 Aug 01, 2022	BUY	$278.73 - $327.27 $2,508 - $2,945	9 Added 0.27%	3,365 $1.08 Million
Q1 2022 Apr 22, 2022	BUY	$234.69 - $291.66 $5,867 - $7,291	25 Added 0.75%	3,356 $1 Million
Q3 2021 Oct 19, 2021	SELL	$221.6 - $272.71 $4,653 - $5,726	-21 Reduced 0.63%	3,331 $788,000
Q2 2021 Jul 21, 2021	SELL	$180.55 - $233.54 $2,166 - $2,802	-12 Reduced 0.36%	3,352 $789,000
Q1 2021 Apr 14, 2021	SELL	$164.32 - $212.72 $32,206 - $41,693	-196 Reduced 5.51%	3,364 $622,000
Q4 2020 Jan 19, 2021	BUY	$130.46 - $172.63 $521 - $690	4 Added 0.11%	3,560 $592,000
Q2 2020 Jul 13, 2020	SELL	$136.42 - $164.18 $10,913 - $13,134	-80 Reduced 2.2%	3,556 $593,000
Q1 2020 Apr 17, 2020	SELL	$119.05 - $147.35 $22,143 - $27,407	-186 Reduced 4.87%	3,636 $550,000
Q4 2019 Feb 04, 2020	SELL	$106.92 - $132.43 $10,478 - $12,978	-98 Reduced 2.5%	3,822 $539,000
Q3 2019 Oct 15, 2019	BUY	$106.79 - $116.16 $11,212 - $12,196	105 Added 2.75%	3,920 $420,000
Q1 2019 Apr 10, 2019	SELL	$111.31 - $131.02 $6,010 - $7,075	-54 Reduced 1.4%	3,815 $479,000
Q4 2018 Jan 22, 2019	BUY	$105.9 - $118.64 $409,727 - $459,018	3,869 New	3,869 $448,000

Others Institutions Holding LLY

# of Institutions

3,721

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $862B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dfpg Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dfpg Investments, LLC with notifications on news.

Account

Dfpg Investments, LLC Eli Lilly & CO Transaction History